Form 4 for NUVB Nuvation Bio Inc.
Accepted 2025-06-18 00:00:00 ET · period of report 2025-06-16 · accession 0001415889-25-017659 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-18 | 2025-06-16+ | NUVB | Sauvage Philippe | CFO | P - Purchase | $1.81 | +7,300 | 9,902 | +281% | +$13.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-06-16 | P | A | 3,300 | $1.84 | 5,902 | D | — | — | (F1) Includes 2,602 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. |
| 2 | Common | Class A Common Stock | 2025-06-17 | P | A | 4,000 | $1.79 | 9,902 | D | — | — |